India-based Advinus Therapeutics has expanded its operations to the U.S. by incorporating a fully owned business unit that will be based at North Carolina's Research Triangle Park. The move is aimed at fostering and boosting drug-discovery partnerships with U.S. pharmaceutical and biotech firms, said Advinus CEO and Managing Director Rashmi Barbhaiya.

Related Summaries